Correction to: A placebo‑controlled, double‑blind, randomized study of recombinant thrombomodulin (ART‑123) to prevent oxaliplatin‑induced peripheral neuropathy

Masahito Kotaka; Yoji Saito; Takeshi Kato; Hironaga Satake; Akitaka Makiyama; Yasushi Tsuji; Katsunori Shinozaki; Toshiyoshi Fujiwara; Tsunekazu Mizushima; Yasushi Harihara; Naoki Nagata; Naoto Kurihara; Masahiko Ando; Genichi Kusakawa; Takumi Sakai; Yugo Uchida; Mikihiro Takamoto; Saki Kimoto; Ichinosuke Hyodo

doi:10.1007/s00280-020-04185-y

Correction to: A placebo‑controlled, double‑blind, randomized study of recombinant thrombomodulin (ART‑123) to prevent oxaliplatin‑induced peripheral neuropathy

Cancer Chemother Pharmacol. 2021 Apr;87(4):585-586. doi: 10.1007/s00280-020-04185-y.

Authors

Masahito Kotaka¹, Yoji Saito², Takeshi Kato^{3

4}, Hironaga Satake^{5

6}, Akitaka Makiyama^{7

8}, Yasushi Tsuji⁹, Katsunori Shinozaki¹⁰, Toshiyoshi Fujiwara¹¹, Tsunekazu Mizushima¹², Yasushi Harihara¹³, Naoki Nagata¹⁴, Naoto Kurihara¹⁵, Masahiko Ando¹⁶, Genichi Kusakawa¹⁷, Takumi Sakai¹⁷, Yugo Uchida¹⁷, Mikihiro Takamoto¹⁷, Saki Kimoto¹⁷, Ichinosuke Hyodo^{18

19}

Affiliations

¹ Gastrointestinal Cancer Center, Sano Hospital, 2-5-1 Shimizugaoka, Tarumi-ku, Kobe-shi, Hyogo, 655-0031, Japan. tomomakotaka6410@yahoo.co.jp.
² Department of Anesthesiology, Shimane University Faculty of Medicine, 89-1 Enyacho, Izumo City, Shimane, 693-8501, Japan.
³ Department of Gastroenterological Surgery, Kansai Rosai Hospital, 3-1-69 Inabaso, Amagasaki-shi, Hyogo, 660-8511, Japan.
⁴ Colorectal Surgery, National Hospital Organization Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka City, Osaka, 540-0006, Japan.
⁵ Department of Medical Oncology, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe-city, Hyogo, 650-0047, Japan.
⁶ Cancer Treatment Center, Kansai Medical University Hospital, 2-3-1 Shin-machi, Hirakata City, Osaka, 573-1191, Japan.
⁷ Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, 1-8-1 Kishinoura, Yahatanishi-ku, Kitakyusyu-shi, Fukuoka, 806-8501, Japan.
⁸ Cancer Center, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
⁹ Department of Medical Oncology, Tonan Hospital, Kita 4-jo Nishi 7-chome 3-8, Chuo-ku, Sapporo-shi, Hokkaido, 060-0004, Japan.
¹⁰ Division of Clinical Oncology, Hiroshima Prefectural Hospital, 1-5-54 Ujinakanda, Minami-ku, Hiroshima-shi, Hiroshima, 734-8530, Japan.
¹¹ Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama-city, Okayama, 700-8558, Japan.
¹² Department of Gastrointestinal Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
¹³ Department of Surgery, NTT Medical Center Tokyo, 5-9-22 Higashi-Gotanda, Shinagawa-ku, Tokyo, 141-8625, Japan.
¹⁴ Department of Surgery, Kitakyushu General Hospital, 1-1 Higashijono-machi, Kokurakita-ku, Kitakyushu, 802-8517, Japan.
¹⁵ Department of Surgery, Nerima General Hospital, 1-24-1 Asahigaoka, Nerima-ku, Tokyo, 176-8530, Japan.
¹⁶ Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8560, Japan.
¹⁷ Clinical Development Center, Asahi Kasei Pharma Corporation, 1-1-2 Yurakucho, Chiyoda-ku, Tokyo, 100-0006, Japan.
¹⁸ Division of Gastroenterology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8577, Japan.
¹⁹ Division of Gastrointestinal Medical Oncology, NHO Shikoku Cancer Center, 160 Kou Minami-umemoto, Matsuyama-city, Ehime, 791-0280, Japan.

No abstract available

Publication types

Published Erratum